{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Epilepsy", "Excitotoxicity", "Neurodegeneration", "Neuroinflammation", "Oxidative stress", "Vitamin E"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34507113", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "27"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "09", "Day": "08"}], "Language": ["eng"], "ELocationID": ["10.1016/j.biopha.2021.112146", "S0753-3322(21)00930-6"], "Journal": {"ISSN": "1950-6007", "JournalIssue": {"Volume": "143", "PubDate": {"Year": "2021", "Month": "Nov"}}, "Title": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie", "ISOAbbreviation": "Biomed Pharmacother"}, "ArticleTitle": "Interweaving epilepsy and neurodegeneration: Vitamin E as a treatment approach.", "Pagination": {"StartPage": "112146", "MedlinePgn": "112146"}, "Abstract": {"AbstractText": ["Epilepsy is the most common neurological disorder, affecting nearly 50 million people worldwide. The condition can be manifested either due to genetic predisposition or acquired from acute insult which leads to alteration of cellular and molecular mechanisms. Evaluating the latest and the current knowledge in regard to the mechanisms underlying molecular and cellular alteration, hyperexcitability is a consequence of an imbalanced state wherein enhance excitatory glutamatergic and reduced inhibitory GABAergic signaling is considered to be accountable for seizures associated damage. However, neurodegeneration contributing to epileptogenesis has become increasingly appreciated. The components at the helm of neurodegenerative alterations during epileptogenesis include GABAergic neuronal and receptor changes, neuroinflammation, alteration in axonal transport, oxidative stress, excitotoxicity, and other cellular as well as functional changes. Targeting neurodegeneration with vitamin E as an antioxidant, anti-inflammatory and neuroprotective may prove to be one of the therapeutic approaches useful in managing epilepsy. In this review, we discuss and converse about the seizure-induced episodes as a link for the development of neurodegenerative and pathological consequences of epilepsy. We also put forth a summary of the potential intervention with vitamin E therapy in the management of epilepsy."], "CopyrightInformation": "Copyright \u00a9 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "SNJB's Shriman Sureshdada Jain College of Pharmacy, Neminagar, Chandwad, Nashik, Maharashtra, India."}], "LastName": "Upaganlawar", "ForeName": "Aman B", "Initials": "AB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra, India."}], "LastName": "Wankhede", "ForeName": "Nitu L", "Initials": "NL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra, India."}], "LastName": "Kale", "ForeName": "Mayur B", "Initials": "MB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra, India."}], "LastName": "Umare", "ForeName": "Mohit D", "Initials": "MD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chitkara College of Pharmacy, Chitkara University, Punjab, India."}], "LastName": "Sehgal", "ForeName": "Aayush", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chitkara College of Pharmacy, Chitkara University, Punjab, India."}], "LastName": "Singh", "ForeName": "Sukhbir", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural & Medical Sciences Research Centre, University of Nizwa, Nizwa, Oman."}], "LastName": "Bhatia", "ForeName": "Saurabh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural & Medical Sciences Research Centre, University of Nizwa, Nizwa, Oman."}], "LastName": "Al-Harrasi", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Vegetable Crops and Medicinal Plants, University of Life Sciences, Lublin, Poland. Electronic address: agnieszka.najda@up.lublin.pl."}], "LastName": "Najda", "ForeName": "Agnieszka", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Vegetable Crops and Medicinal Plants, University of Life Sciences, Lublin, Poland."}], "LastName": "Nurzy\u0144ska-Wierdak", "ForeName": "Renata", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, Romania."}], "LastName": "Bungau", "ForeName": "Simona", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chitkara College of Pharmacy, Chitkara University, Punjab, India. Electronic address: tapanbehl31@gmail.com."}], "LastName": "Behl", "ForeName": "Tapan", "Initials": "T"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "France", "MedlineTA": "Biomed Pharmacother", "NlmUniqueID": "8213295", "ISSNLinking": "0753-3322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anticonvulsants"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Inflammation Mediators"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "1406-18-4", "NameOfSubstance": "Vitamin E"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Anticonvulsants"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["drug effects", "metabolism", "physiopathology"], "DescriptorName": "Brain"}, {"QualifierName": ["drug effects"], "DescriptorName": "Brain Waves"}, {"QualifierName": ["drug therapy", "epidemiology", "metabolism", "physiopathology"], "DescriptorName": "Epilepsy"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Inflammation Mediators"}, {"QualifierName": [], "DescriptorName": "Nerve Degeneration"}, {"QualifierName": ["drug therapy", "epidemiology", "metabolism", "physiopathology"], "DescriptorName": "Neurodegenerative Diseases"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": [], "DescriptorName": "Prognosis"}, {"QualifierName": [], "DescriptorName": "Risk Assessment"}, {"QualifierName": [], "DescriptorName": "Risk Factors"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Vitamin E"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2021", "Month": "7", "Day": "14"}, {"Year": "2021", "Month": "8", "Day": "31"}, {"Year": "2021", "Month": "8", "Day": "31"}, {"Year": "2021", "Month": "9", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "10", "Hour": "20", "Minute": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34507113", "10.1016/j.biopha.2021.112146", "S0753-3322(21)00930-6"]}}], "PubmedBookArticle": []}